Rankings
▼
Calendar
QTTB Q3 2024 Earnings — Q32 Bio Inc. Revenue & Financial Results | Market Cap Arena
QTTB
Q32 Bio Inc.
$73M
Q3 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
-100.0% YoY
Gross Profit
$0
Operating Income
-$19M
Net Income
-$18M
EPS (Diluted)
$-1.46
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$20M
Free Cash Flow
-$20M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$105M
Total Liabilities
$86M
Stockholders' Equity
$18M
Cash & Equivalents
$89M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$2M
-100.0%
Gross Profit
$0
$2M
-100.0%
Operating Income
-$19M
-$8M
-141.3%
Net Income
-$18M
-$14M
-25.4%
← FY 2024
All Quarters
Q4 2024 →